Qualigen Therapeutics, Inc. Quarterly Interest Expense in USD from Q2 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Qualigen Therapeutics, Inc. quarterly/annual Interest Expense history and growth rate from Q2 2019 to Q3 2024.
  • Qualigen Therapeutics, Inc. Interest Expense for the quarter ending September 30, 2024 was $28K, a 92.4% decline year-over-year.
  • Qualigen Therapeutics, Inc. annual Interest Expense for 2019 was $283K.
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $28K -$340K -92.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-14
Q1 2024 $68K Jan 1, 2024 Mar 31, 2024 10-Q 2024-07-02
Q3 2023 $368K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q3 2020 $715 -$64.8K -98.9% Jul 1, 2020 Sep 30, 2020 10-Q 2020-11-12
Q2 2020 $57.4K -$12.6K -18% Apr 1, 2020 Jun 30, 2020 10-Q 2020-08-14
Q3 2019 $65.5K Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $70K Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.